157 related articles for article (PubMed ID: 30351481)
21. Chemical structure of the core oligosaccharide of aerotolerant Campylobacter jejuni O:2 lipopolysaccharide.
Hanniffy OM; Shashkov AS; Moran AP; Senchenkova SN; Savage AV
Carbohydr Res; 2001 Jan; 330(2):223-9. PubMed ID: 11217975
[TBL] [Abstract][Full Text] [Related]
22. [Pathogenesis of axonal Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
[TBL] [Abstract][Full Text] [Related]
23. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
24. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.
Godschalk PC; Heikema AP; Gilbert M; Komagamine T; Ang CW; Glerum J; Brochu D; Li J; Yuki N; Jacobs BC; van Belkum A; Endtz HP
J Clin Invest; 2004 Dec; 114(11):1659-65. PubMed ID: 15578098
[TBL] [Abstract][Full Text] [Related]
25. [Campylobacter genes responsible for the development and determinant of clinical features of Guillain-Barré syndrome].
Yuki N
Nihon Rinsho; 2008 Jun; 66(6):1205-10. PubMed ID: 18540372
[TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure.
Aspinall GO; Fujimoto S; McDonald AG; Pang H; Kurjanczyk LA; Penner JL
Infect Immun; 1994 May; 62(5):2122-5. PubMed ID: 8168981
[TBL] [Abstract][Full Text] [Related]
27. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
[TBL] [Abstract][Full Text] [Related]
28. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.
Aspinall GO; McDonald AG; Pang H; Kurjanczyk LA; Penner JL
Biochemistry; 1994 Jan; 33(1):241-9. PubMed ID: 8286348
[TBL] [Abstract][Full Text] [Related]
29. Diversity-oriented synthesis of inner core oligosaccharides of the lipopolysaccharide of pathogenic Gram-negative bacteria.
Yang Y; Oishi S; Martin CE; Seeberger PH
J Am Chem Soc; 2013 Apr; 135(16):6262-71. PubMed ID: 23521711
[TBL] [Abstract][Full Text] [Related]
30. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
Shu XM; Cai FC; Zhang XP
Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
[TBL] [Abstract][Full Text] [Related]
31. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
32. PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome.
Godschalk PC; van Belkum A; van den Braak N; van Netten D; Ang CW; Jacobs BC; Gilbert M; Endtz HP
J Clin Microbiol; 2007 Jul; 45(7):2316-20. PubMed ID: 17507514
[TBL] [Abstract][Full Text] [Related]
33. The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome.
Xiang SL; Zhong M; Cai FC; Deng B; Zhang XP
J Neuroimmunol; 2006 May; 174(1-2):126-32. PubMed ID: 16567003
[TBL] [Abstract][Full Text] [Related]
34. Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides.
Avril T; Wagner ER; Willison HJ; Crocker PR
Infect Immun; 2006 Jul; 74(7):4133-41. PubMed ID: 16790787
[TBL] [Abstract][Full Text] [Related]
35. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
Hye JB; Nachamkin I
Neurology; 2007 May; 68(19):1633-4. PubMed ID: 17485654
[No Abstract] [Full Text] [Related]
36. T cell response in acute motor axonal neuropathy.
Cencioni MT; Notturno F; Caporale CM; Creati B; Prencipe V; Battistini L; Uncini A
Int J Immunopathol Pharmacol; 2009; 22(4):1043-50. PubMed ID: 20074468
[TBL] [Abstract][Full Text] [Related]
37. Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.
Poly F; Read TD; Chen YH; Monteiro MA; Serichantalergs O; Pootong P; Bodhidatta L; Mason CJ; Rockabrand D; Baqar S; Porter CK; Tribble D; Darsley M; Guerry P
Infect Immun; 2008 Dec; 76(12):5655-67. PubMed ID: 18809665
[TBL] [Abstract][Full Text] [Related]
38. Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barré syndrome, by horizontal exchange.
Gilbert M; Godschalk PC; Karwaski MF; Ang CW; van Belkum A; Li J; Wakarchuk WW; Endtz HP
Infect Immun; 2004 Feb; 72(2):1162-5. PubMed ID: 14742567
[TBL] [Abstract][Full Text] [Related]
39. Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice.
Huizinga R; Easton AS; Donachie AM; Guthrie J; van Rijs W; Heikema A; Boon L; Samsom JN; Jacobs BC; Willison HJ; Goodyear CS
PLoS One; 2012; 7(3):e34416. PubMed ID: 22470569
[TBL] [Abstract][Full Text] [Related]
40. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
